Mode
Text Size
Log in / Sign up
N/A N=60 Treatment

Medtronic Closed-Loop Spinal Cord Stimulation System

Low Back Pain · Leg Pain · Upper Limb Pain

Enrolled (actual)
60
Serious AEs
16.7%
Results posted
Oct 2024
Primary outcome: Primary: Reduction in Overstimulation Sensation — 25 Participants — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Inceptiv (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
MedtronicNeuro
Primary completion
May 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Reduction in Overstimulation Sensation
25 <0.001 sig
SECONDARY
Responder Rate for Treatment of Overall Pain
44
SECONDARY
Responder Rate for Treatment of Low-back Pain
38
SECONDARY
Responder Rate for Treatment of Leg Pain
30

Summary

The purpose of the study is to further understand the closed-loop feature in chronically implanted patients by characterizing the efficacy of the next generation, spinal cord stimulator.

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Candidate is undergoing Medtronic SCS device trial for chronic, intractable pain of the trunk and/or limbs
  • If being treated for low-back and/or leg pain,
  • the baseline overall^ Visual Analog Scale is ≥ 60 mm and
  • baseline back and/or leg pain Visual Analog Scale is ≥60 mm. ^Average overall pain in the back and/or leg in the 72 hours prior to the baseline visit, measured using Visual Analog Scale.
  • If being treated for upper limb pain - baseline Visual Analog Scale is ≥ 60 mm for upper limb pain
  • On stable (no change in dose, route, or frequency) prescribed pain medications being used for back and leg pain or upper limb pain, as determined by the investigator, for at least 28 days prior to device trial
  • Willing and able to provide signed and dated informed consent
  • Willing and able to comply with all study procedures and visits

Exclusion Criteria

  • Indicated for an SCS device to treat stable intractable Angina Pectoris or Peripheral Vascular Disease of Fontaine Stage III or higher
  • Previously trialed or implanted with spinal cord stimulator, peripheral or vagus nerve stimulator, deep brain stimulator or an implantable intrathecal drug delivery system
  • Currently participating, or plans to participate, in another investigational study unless written approval is provided by the Medtronic study team
  • Major psychiatric comorbidity or other progressive diseases that may confound study results, as determined by the Investigator
  • Serious drug-related behavioral issues (e.g. alcohol dependency, illegal substance abuse), as determined by the Investigator
  • Pregnant or planning on becoming pregnant (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile, or be at least 2 years post-menopausal)
  • Be involved in an injury claim or under current litigation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05177354). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search